Journal History

2009 The inaugural issue was released. Pharmaceutics was published as a quarterly journal.
2013 Pharmaceutics was indexed in PubMed (Citations were available in PubMed, full-text was archived in PubMed Central).
2017 Pharmaceutics was indexed in Science Citation Index Expanded (SCIE).
Pharmaceutics announced the first edition of the Travel Award.
2018 Pharmaceutics received its first Impact Factor (3.746).
Pharmaceutics announced the first edition of the Young Investigator Award.
Pharmaceutics published its 500th paper.
2019 Pharmaceutics adopted a monthly publication schedule.
The Impact Factor increased to 4.773.
The Academy of Pharmaceutical Sciences (APS), Korean Society of Pharmaceutical Sciences and Technology (KSPST), Pharmaceutical Solid State Research Cluster (PSSRC), and Spanish Society of Pharmaceutics and Pharmaceutical Technology (SEFIG) became affiliated to Pharmaceutics.
Pharmaceutics published its 1,000th paper.
2020 Pharmaceutics held the 1st International Electronic Conference.
Pharmaceutics established the following sections:
  • Nanomedicine and Nanotechnology;
  • Pharmaceutical Technology, Manufacturing and Devices;
  • Physical Pharmacy and Formulation;
  • Biopharmaceutics;
  • Drug Delivery and Controlled Release;
  • Pharmacokinetics and Pharmacodynamics;
  • Gene and Cell Therapy;
  • Drug Targeting and Design;
  • Biologics and Biosimilars;
  • Clinical Pharmaceutics.
Pharmaceutics received its 2019 Impact Factor (4.421).
2021 The Impact Factor increased to 6.321.
2022 Pharmaceutics published its 5,000th paper.
The Impact Factor increased to 6.525.
2023 Pharmaceutics received its 2022 Impact Factor (5.4), ranked Q1 in JRS Category “Pharmacology and Pharmacy”.
The CiteScore increased to 6.9.

Editor-in-Chief

2009–2023 Editor-in-Chief: Prof. Dr. Yvonne Perrie
2023–present Editor-in-Chief: Prof. Dr. Patrick J. Sinko

Section Editor-in-Chief

2020–2023 Section Editor-in-Chief: Prof. Dr. Yvonne Perrie for the section on Drug Delivery and Controlled Release
2020–present  Section Editor-in-Chief: Prof. Dr. Beom Soo Shin for the section on Pharmacokinetics and Pharmacodynamics
Section Editor-in-Chief: Prof. Dr. Donatella Paolino for the section on Nanomedicine and Nanotechnology
Section Editor-in-Chief: Prof. Dr. Thierry Vandamme for the section on Pharmaceutical Technology, Manufacturing and Devices
Back to TopTop